EMAIL THIS PAGE TO A FRIEND

Infection and immunity

Isolation site influences virulence phenotype of serotype 14 Streptococcus pneumoniae strains belonging to multilocus sequence type 15.


PMID 26416904

Abstract

Streptococcus pneumoniae is a diverse species causing invasive as well as localized infections that result in massive global morbidity and mortality. Strains vary markedly in pathogenic potential, but the molecular basis is obscured by the diversity and plasticity of the pneumococcal genome. We have previously reported that S. pneumoniae serotype 3 isolates belonging to the same multilocus sequence type (MLST) differed markedly in in vitro and in vivo phenotypes, in accordance with the clinical site of isolation, suggesting stable niche adaptation within a clonal lineage. In the present study, we have extended our analysis to serotype 14 clinical isolates from cases of sepsis or otitis media that belong to the same MLST (ST15). In a murine intranasal challenge model, five ST15 isolates (three from blood and two from ears) colonized the nasopharynx to similar extents. However, blood and ear isolates exhibited significant differences in bacterial loads in other host niches (lungs, ear, and brain) at both 24 and 72 h postchallenge. In spite of these differences, blood and ear isolates were present in the lungs at similar levels at 6 h postchallenge, suggesting that early immune responses may underpin the distinct virulence phenotypes. Transcriptional analysis of lung tissue from mice infected for 6 h with blood isolates versus ear isolates revealed 8 differentially expressed genes. Two of these were exclusively expressed in response to infection with the ear isolate. These results suggest a link between the differential capacities to elicit early innate immune responses and the distinct virulence phenotypes of clonally related S. pneumoniae strains.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB3700855 Anti-Rabbit IgG (Fc specific), highly cross adsorbed-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700854 Anti-Rabbit IgG (Fc specific)-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700950 Anti-Rabbit IgG (H+L), F(ab′)2 fragment-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A3937 Anti-Rabbit IgG (whole molecule), F(ab′)2 fragment−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A8025 Anti-Rabbit IgG (whole molecule)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A9919 Anti-Rabbit IgG (whole molecule)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A7539 Anti-Rabbit IgG (whole molecule)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A0418 Anti-Rabbit IgG (whole molecule)–Alkaline Phosphatase antibody produced in goat, IgG fraction of antiserum
SAB3700843 Anti-Rabbit IgG F(ab′)2, F(ab′)2 fragment, highly cross absorbed-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700834 Anti-Rabbit IgG F(ab′)2, highly cross adsorbed-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700833 Anti-Rabbit IgG F(ab′)2-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution